Search

everythinglearnresearchcommunity

for

Search:↓

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Baricitinib may help people with long-term alopecia areata.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Deleting TNFα gene reduces skin cancer risk in certain mice.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

A new therapy for a skin blistering condition has not been developed yet.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Intralesional cidofovir might be a good alternative treatment.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.